Your session is about to expire
← Back to Search
Electronic Health System Enhancement for Colon Cancer (CLOVER Trial)
N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial uses a software tool called Epic Healthy Planet to help doctors keep track of health guidelines for patients aged 50 and older. The goal is to make sure these patients follow important health recommendations from major health organizations. The software reminds both doctors and patients about necessary check-ups and preventive measures.
Who is the study for?
This trial is for adults aged 50 and older who are patients at UC Davis or UC Irvine with a primary care provider. It's for those needing colon or lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia or shingles vaccination, and hepatitis C screening.
What is being tested?
The trial is testing the Epic Healthy Planet Population Health Module to see if it helps increase adherence to preventive health recommendations by the USPSTF and CDC in people over age 50.
What are the potential side effects?
Since this trial involves a health system intervention rather than medication, traditional side effects aren't expected. However, there may be indirect effects related to changes in healthcare management.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Overall Adherence to CLOVER Metrics
Secondary study objectives
Colon cancer screening
Hepatitis C screening
Lung cancer screening
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CLOVER armExperimental Treatment1 Intervention
This arm will contain clinics that utilize the CLOVER intervention
Group II: Standard of Care armActive Control1 Intervention
This arm will contain clinics that do not utilize the CLOVER intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Shingles (Herpes Zoster) include antiviral medications such as acyclovir, valacyclovir, and famciclovir. These antivirals work by inhibiting viral DNA replication, thereby reducing the severity and duration of the infection.
Pain management is also crucial, often involving analgesics, corticosteroids, and sometimes nerve blocks. For Shingles patients, adherence to these treatments is vital to prevent complications such as postherpetic neuralgia.
Population health management tools like Epic Healthy Planet can play a significant role by ensuring timely administration of these treatments, monitoring patient adherence, and providing reminders for follow-up care, ultimately improving patient outcomes.
Testing for saturation in qualitative evidence syntheses: An update of HIV adherence in Africa.Self-management interventions in systemic sclerosis: A systematic review.The International Society for Traumatic Stress Studies New Guidelines for the Prevention and Treatment of Posttraumatic Stress Disorder: Methodology and Development Process.
Testing for saturation in qualitative evidence syntheses: An update of HIV adherence in Africa.Self-management interventions in systemic sclerosis: A systematic review.The International Society for Traumatic Stress Studies New Guidelines for the Prevention and Treatment of Posttraumatic Stress Disorder: Methodology and Development Process.
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
945 Previous Clinical Trials
4,736,140 Total Patients Enrolled
2 Trials studying Pneumonia
180 Patients Enrolled for Pneumonia
University of California, IrvineOTHER
565 Previous Clinical Trials
1,912,958 Total Patients Enrolled
1 Trials studying Pneumonia
59 Patients Enrolled for Pneumonia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- If you have a primary care provider at UC Davis or UC Irvine, you need to have received certain health screenings and counseling for conditions like colon cancer, lung cancer, tobacco cessation, obesity, pneumonia, shingles, and hepatitis C.
Research Study Groups:
This trial has the following groups:- Group 1: CLOVER arm
- Group 2: Standard of Care arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.